Revolve Wealth Partners LLC Reduces Stock Holdings in Intuitive Surgical, Inc. $ISRG

Revolve Wealth Partners LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,080 shares of the medical equipment provider’s stock after selling 54 shares during the period. Revolve Wealth Partners LLC’s holdings in Intuitive Surgical were worth $1,130,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Chilton Capital Management LLC grew its stake in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares in the last quarter. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical during the first quarter valued at $26,000. LFA Lugano Financial Advisors SA purchased a new stake in shares of Intuitive Surgical during the first quarter valued at $30,000. TD Capital Management LLC lifted its stake in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares in the last quarter. Finally, 1248 Management LLC purchased a new stake in Intuitive Surgical in the 1st quarter worth about $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In related news, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 in the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $435.73 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock has a market capitalization of $156.20 billion, a PE ratio of 60.77, a PEG ratio of 4.51 and a beta of 1.61. The business has a fifty day moving average price of $457.73 and a two-hundred day moving average price of $497.44.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical’s revenue was up 21.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.78 EPS. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Truist Financial increased their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. The Goldman Sachs Group dropped their price target on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a report on Wednesday, October 1st. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, October 4th. UBS Group set a $529.00 price objective on Intuitive Surgical in a research note on Monday. Finally, Evercore ISI reduced their target price on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a report on Tuesday, October 7th. Fourteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $584.76.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.